News

Merck to Buy Verona Pharma in $10 Billion Deal
The move bolsters Merck's lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda.
Verona Pharma Stock Soars to All-Time High as Merck Buys Firm for $10B
Merck said the deal is valued at $107 per ADS, a 23% premium to Verona’s closing price yesterday.
Fierce Pharma13h
Merck boosts respiratory portfolio with $10B acquisition of Verona and potential COPD blockbuster Ohtuvayre
Merck has pulled off another acquisition which fits in its “sweet spot,” as described by CEO Rob Davis, paying $10 billion ...
BioPharma Dive13h
Merck to buy Verona and its lung drug in $10B deal
The New Jersey-based pharma has inked one of the biggest deals of the year in pursuit of a promising new way to treat COPD.
Verona man sentenced for child pornography possession
A Verona man accused of possessing child pornography pleaded guilty to several felonies in Augusta Circuit Court.
These Stocks Are Moving the Most Today: Nvidia, AES, Verona Pharma, WPP, Bloom Energy, Aehr Test Systems, and More
Stocks traded higher Wednesday as Wall Street focused on the latest tariff developments from President Donald Trump and ...
Channel 30008h
Verona's ART House 360 to open with multicultural focus
A new multicultural arts space in Verona is set to open on Aug. 14, promising an arts center designed for people of all ages ...
Health Care Climbs After Verona Deal - Health Care Roundup
Health-care companies rose as deal activity offset more health-insurance controversy. Merck struck a roughly $10 billion deal to buy Verona Pharma, bolstering its lineup with the chronic obstructive ...